AstraZeneca wants to make its oral selective oestrogen receptor degrader (SERD) drug camizestrant a go-to frontline therapy for HR-positive breast cancer, and made its case at ASCO with data from the ...
Title: Results from the randomized Phase 2 study (1801 Part 3B) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) versus GnP in previously untreated metastatic ...
CHICAGO and FORT WORTH, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) ("Actuate” or the "Company”), a clinical-stage biopharmaceutical company focused on ...
2 Florida Publix stores sold a winning Mega Millions and Powerball ticket worth $1.58 billion. Edwin Castro of Altadena, California, won $2.04 billion Powerball in November 2022. He claimed the cash ...
Dan Shaughnessy is a sports columnist and associate editor at the Boston Globe. He was born in Groton, Massachusetts, graduated from Holy Cross, and worked part-time at the Boston Globe from 1973-77.
Albert Ludolph, MD, lead author and Senior Professor of Neurology at the University of Ulm, stated: "Our findings highlight the importance of early intervention in ALS with masitinib, demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback